Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about PRVB
Recent news which mentions PRVB
< Previous
1
2
3
4
Next >
Tiziana Life Sciences (NASDAQ: TLSA) Announces Positive Data In Its Secondary-Progressive Multiple Sclerosis Trial, What Could This Mean For The Company?
June 15, 2023
Tickers
PRVB
SNY
TLSA
Tags
Penny Stocks
Market News
TLSA
From
Benzinga
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
April 19, 2023
Tickers
EWTX
IPHA
PRVB
SGEN
Tags
Penny Stocks
Biotech
Benzinga
From
Benzinga
Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce – Tiziana Life Sciences' (NASDAQ: TLSA) First-In-Class Foralumab Is Showing Promise
April 12, 2023
Tickers
PRVB
SNY
TLSA
Tags
Partner Content
Benzinga
Biotech
From
Benzinga
Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information
April 11, 2023
Tickers
PRVB
SNY
Tags
Market News
Legal
Large Cap
From
Benzinga
Is Sanofi Stock a Buy Now?
March 25, 2023
Tickers
PRVB
SNY
Tags
Market News
SNY
PRVB
From
Motley Fool
Top 5 Health Care Stocks That May Crash In March
March 22, 2023
Tickers
BLPH
CRBP
JNCE
PRVB
Tags
BLPH
PRVB
Overbought stocks
From
Benzinga
Why Provention Bio Stock Skyrocketed 256% This Week
March 16, 2023
Tickers
PRVB
SNY
Tags
Recent Press Releases
PRVB
SNY
From
Motley Fool
Why Shares of MacroGenics Climbed Thursday
March 16, 2023
Tickers
INCY
MGNX
PRVB
Tags
Market News
MGNX
INCY
From
Motley Fool
Provention Bio's Earnings Outlook
March 15, 2023
Tickers
PRVB
Tags
Earnings
Market News
BZI/EP
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023
March 15, 2023
Tickers
AIRC
AMPL
APEI
AZUL
Tags
TFC
Benzinga
CP
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
March 14, 2023
Tickers
ACLX
ASO
CBU
CDMO
Tags
Market News
TRUE
LX
From
Benzinga
Top 5 Health Care Stocks That Are Ticking Portfolio Bombs
March 14, 2023
Tickers
AMYT
CSII
IMRX
PRVB
Tags
Benzinga
Overbought stocks
Markets
From
Benzinga
4 Analysts Have This to Say About Provention Bio
March 14, 2023
Tickers
PRVB
Tags
BZI/AAR
PRVB
Benzinga
From
Benzinga
Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners
March 13, 2023
Tickers
DJI
PFE
PRVB
SGEN
Tags
SNY
PRVB
Recent Press Releases
From
Motley Fool
Nasdaq Up 150 Points; Gold Rises Over 2%
March 13, 2023
Tickers
BVH
CALT
FRC
ILMN
Tags
KEN
News
FRC
From
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 13, 2023
Tickers
BDTX
BYSI
CALT
CING
Tags
GCTK
Benzinga
LPCN
From
Benzinga
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 13, 2023
Tickers
ARDS
AUST
CALT
CIFR
Tags
TENX
KNTE
ILMN
From
Benzinga
Dow Jumps 300 Points; Crude Oil Down 1%
March 13, 2023
Tickers
BVH
CALT
CUBI
FRC
Tags
CUBI
Global
Penny Stocks
From
Benzinga
Provention Bio's $2.9B Acquisition - A Strategic Fit For Sanofi
March 13, 2023
Tickers
PRVB
SNY
Tags
Movers
Briefs
General
From
Benzinga
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
March 13, 2023
Tickers
AG
AGEN
AU
CALT
Tags
CIFR
CALT
PRVB
From
Benzinga
Regional banks pace decliners, as biotech deals lift Seagen and Provention Bio
March 13, 2023
Tickers
BAC
CS
FRC
JPM
Tags
PFE
PACW
CS
From
MarketWatch
US Stocks Mostly Higher; Dow Rises 75 Points
March 13, 2023
Tickers
BVH
CALT
CMND
CUBI
Tags
Small Cap
Markets
Commodities
From
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 13, 2023
Tickers
ARDS
BYSI
CALT
CING
Tags
Market News
TFFP
QLI
From
Benzinga
Why Is First Republic Bank (FRC) Stock Down 61% Today?
March 13, 2023
Tickers
FRC
PRVB
SNCE
Tags
NYSE:FRC,NASDAQ:SNCE,NASDAQ:PRVB
SNCE
Market News
From
InvestorPlace
Why Provention Bio Stock Is Rocketing Past 52-Week Highs Today
March 13, 2023
Tickers
PRVB
SNY
Tags
PRVB
Biotech
Benzinga
From
Benzinga
Why Is Science 37 (SNCE) Stock Up 9% Today?
March 13, 2023
Tickers
PRVB
SNCE
Tags
NASDAQ:SNCE,NASDAQ:PRVB
Today's Market
PRVB
From
InvestorPlace
Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
March 13, 2023
Tickers
ACAD
CING
CYTO
CZOO
Tags
FRC
METX
CZOO
From
Benzinga
Why Is Provention Bio (PRVB) Stock Up 263% Today?
March 13, 2023
Tickers
PRVB
SNY
Tags
Market News
SNY
PRVB
From
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
March 13, 2023
Tickers
AGBA
AKAN
ANY
AULT
Tags
BLDE
CMND
SNCE
From
InvestorPlace
Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows
March 13, 2023
Tickers
AMGN
FRC
HSBC
ILMN
Tags
QQQ
PRVB
TSLA
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today